Cell Dissociation Markets, 2026 by Product (Enzymatic, Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial) - ResearchAndMarkets.com

·3 min read

DUBLIN, Jun 15, 2021--(BUSINESS WIRE)--The "Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period.

The growth in this market is attributed to the prevalence of cell-based research, the increasing number of pharmaceutical and biotechnology companies. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the cell dissociation market during the forecast period.

Enzymatic dissociation products segment to witness the highest growth during the forecast period.

Based on the product, the cell dissociation market is segmented into Enzymatic dissociation products, Non-Enzymatic dissociation products, and instruments. The Enzymatic dissociation products segment is projected to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed increasing incidence of cell-based research is the major factor supporting the growth of this segment.

Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period.

Based on the tissue, the cell dissociation market is segmented into connective tissues, epethilial tissues, and other tissues (skeletal, muscle tissues). The connective tissues segment is projected to witness the highest growth in the cell dissociation market during the forecast period. The large share of this segment can be attributed to cell-based research and development in pharmaceutical and biotechnology companies.

Asia Pacific is estimated to register the highest CAGR during the forecast period.

In this report, the cell dissociation market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by The increasing funding for cell-based research.

Market Dynamics

Drivers

  • Increasing R&D Activities in Biopharmaceutical Companies

  • Favorable Funding Scenario for Cancer Research

  • Increasing Incidence and Prevalence of Chronic and Infectious Diseases

  • Growing Focus on Personalized Medicine

  • Increasing Government Funding for Cell-Based Research

Restraints

  • High Cost of Cell-Based Research

  • Lack of Infrastructure for Cell-Based Research in Emerging Economies

Opportunities

  • Growth Opportunities in Emerging Markets

  • Growth in Stem Cell Research

  • Emergence of Advanced Tissue Dissociation Enzyme Products

  • Acceptance of Enzyme-Free Dissociation Products Over Enzymatic Dissociation Products

Challenges

  • Survival of Small Players and New Entrants

  • Ethical Concerns Regarding Research in Cell Biology

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Market Overview

4 Executive Summary

5 Premium Insights

6 Cell Dissociation Market, by Product

7 Cell Dissociation Market, by Tissue

8 Cell Dissociation Market, by Type

9 Cell Dissociation Market, by End-user

10 Cell Dissociation Market, by Region

11 Competitive Landscape

12 Company Profiles

Key Players

  • Thermo Fisher Scientific

  • Merck Kgaa

  • Becton, Dickinson and Company

  • Stemcell Technologies

  • Promocell Gmbh

  • F. Hoffmann-La Roche Ltd.

  • Cytiva (A Subsidiary of Danaher Corporation)

  • Miltenyi Biotec

  • Atcc

  • Corning Inc.

  • Himedia Laboratories

  • Pan-Biotech

  • Accegen

  • Cellsystems Gmbh

  • Amsbio

Other Players

  • Vitacyte

  • Alstembio Cell Advancement

  • Biological Industries

  • Gemini Bio-Products

  • Innovative Cell Technologies, Inc.

  • Central Drug House (P) Ltd.

  • R&D Systems (Bio-Techne)

  • Worthington Biochemical Corporation

  • Capricorn Scientific

  • Abeomics

  • Genlantis

  • Neuromics

For more information about this report visit https://www.researchandmarkets.com/r/dgi4ud

View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005925/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting